Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Zhiyu Biotechnology

Request full access

AI-powered synthetic biology for sustainable bio-based materials

ChinaFounded 2021

About Shanghai Zhiyu Biotechnology

Shanghai Zhiyu Biotechnology Co., Ltd., also known as Zelixir, is a company operating at the intersection of artificial intelligence and synthetic biology. Founded in 2021 by a team with expertise in molecular structure prediction, design algorithms, and synthetic biology, the firm aims to innovate the entire synthetic biology process using AI and biocomputing. The company's CEO is Dr. Sheng Wang.

Zelixir's core business revolves around the research, development, and production of bio-based raw materials for a variety of industries, including food, cosmetics, healthcare, and new materials. The company leverages its proprietary AI platforms—Yu Cloud ZCloud, Zhihui ZBot, and Zhishan ZPod—to redesign the synthetic biology workflow, from reaction pathway design and enzyme engineering to scaled-up production. This AI-driven approach is designed to significantly reduce R&D costs and accelerate the commercialization timeline for new products.

The company serves clients in sectors such as medical health, agriculture, food, consumer goods, and chemicals by offering high-quality bio-based materials and integrated research, production, and sales solutions. A key achievement is the development and impending large-scale production of Sustainable Natural Vanillin ex-Ferulic Acid. This product, created using AI-optimized enzymes, offers a sustainable and stable alternative to both natural and chemically synthesized vanillin and has received FEMA GRAS certification under the FDA. In late 2024, Zelixir announced the operational launch of a new green manufacturing plant in Changzhou, Jiangsu Province, to scale the production of its bio-based materials.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
13.0/100
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2023 $14M $55M Shanghai Hongjia Private Equity Fund Management · Qiantang Industry Development Group · HM Capital · Ningbo Hongfeng Investment Management ↗
SEED✓Equity / VC May 2022 $6.9M $28M Hillhouse Capital —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Shanghai Zhiyu Biotechnology website traffic

Latest recorded traffic for Shanghai Zhiyu Biotechnology is 460 monthly website visits, down 44.6% over the last three months.

Latest monthly visits460 3-month web change-44.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Zhiyu Biotechnology in its local ecosystem

Live from Dealroom

The Shanghai Zhiyu Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A4 investors entered at this stage

  • Shanghai Hongjia Private Equity Fund Management
  • Qiantang Industry Development Group
  • HM Capital
  • Ningbo Hongfeng Investment Management
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Zhiyu Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Zhiyu Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.